1292 PUBLICATION Effectivness of recombinant human erythropoietin (epoetin beta, EPO) in improving hematological parameters and QOL in patients with chemotherapy-induced anemia. a double-blind, parallel-group, dose-finding study

首页> 外文期刊>European Journal of Cancer Supplements >1292 PUBLICATION Effectivness of recombinant human erythropoietin (epoetin beta, EPO) in improving hematological parameters and QOL in patients with chemotherapy-induced anemia. a double-blind, parallel-group, dose-finding study

【24h】

1292 PUBLICATION Effectivness of recombinant human erythropoietin (epoetin beta, EPO) in improving hematological parameters and QOL in patients with chemotherapy-induced anemia. a double-blind, parallel-group, dose-finding study

机译：1292出版物重组人促红细胞生成素（epoetin beta，EPO）在改善化疗引起的贫血患者的血液学参数和QOL中的作用。一项双盲，平行组剂量寻找研究

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2005年第2期|共1页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献

1. Once-weekly epoetin-beta improves hemoglobin levels in cancer patients with chemotherapy-induced anemia: A randomized, double-blind, dose-finding study. [J] . Morishima Y, Ogura M, Yoneda S, Japanese journal of clinical oncology. . 2006,第10期

机译：每周一次的epoetin-beta可以改善患有化疗引起的贫血的癌症患者的血红蛋白水平：一项随机，双盲，剂量确定性研究。
2. Once-Weekly Epoetin-Beta Improves Hemoglobin Levels in Cancer Patients with Chemotherapy-Induced Anemia: A Randomized, Double-Blind, Dose-Finding Study [J] . Yasuo Morishima, Michinori Ogura, Shuichi Yoneda, Japanese Journal of Clinical Oncology . 2006,第10期

机译：每周一次依泊汀-β改善患有化疗引起的贫血的癌症患者的血红蛋白水平：一项随机，双盲，剂量研究
3. Randomized, double-blind, placebo-controlled trial of recombinant human erythropoietin, epoetin Beta, in hematologic malignancies. [J] . Osterborg A, Brandberg Y, Molostova V, Journal of Clinical Oncology . 2002,第10期

机译：重组人促红细胞生成素，epoetin Beta在血液系统恶性肿瘤中的随机，双盲，安慰剂对照试验。
4. Unit dosing of darbepoetin alfa for thetreatment of anemia in patients with end-stage renal disease being switched from recombinant human erythropoietin: Results of a phase IIIb 27-week multicenter open-label study in Greek patients [O] . Georgios Bristoyiannis, Nikolaos Germanos, Dimitrios Grekas, 2005

机译：从重组人促红细胞生成素转换为晚期肾病患者贫血治疗中达比泊汀α的单位剂量：一项针对希腊患者的27b周多中心开放性研究的IIIb期研究结果
5. Once-Weekly Epoetin-Beta Improves Hemoglobin Levels in Cancer Patients with Chemotherapy-Induced Anemia: A Randomized, Double-Blind, Dose-Finding Study [O] . Yasuo Morishima, Michinori Ogura, Shuichi Yoneda, 2006

机译：每周一次Epoetin-β改善了癌症患者的血红蛋白水平，化疗诱导的贫血患者：随机，双盲，剂量寻找研究

1292 PUBLICATION Effectivness of recombinant human erythropoietin (epoetin beta, EPO) in improving hematological parameters and QOL in patients with chemotherapy-induced anemia. a double-blind, parallel-group, dose-finding study

著录项

相似文献

相关主题

期刊订阅